Tech Company M&A Transactions
Amplyx Pharmaceuticals Acquisition
On 4/28/2021, Amplyx Pharmaceuticals was bought by Pfizer. The companies did not announce any financial terms for the deal.
Transaction Overview
Company Name
Acquired By
Announced On
4/28/2021
Transaction Type
M&A
Amount
Unknown
M&A Terms
The acquisition of Amplyx follows an initial equity investment by Pfizer in December 2019 as part of Amplyx's Series C financing. Financial terms of this acquisition were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12730 High Bluff Dr. 160
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Amplyx Pharmaceuticals is developing novel, broad-spectrum antifungal agents for the treatment of life-threatening fungal infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Michael Grey
Chief Executive Officer
Ciara Kennedy
Chief Financial Officer
Alan Fuhrman
Chief Medical Officer
Michael Hodges
VP - Bus. Development
Kevin Holme
VP - Operations
Paul Bien
VP - Operations
Pamela Wedel
VP - Regulatory Affairs
Elizabeth Gordon
Browse more venture capital transactions:
Prev: 4/28/2021: Cigent Technology venture capital transaction
Next: 4/28/2021: Automox venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs